CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (7,032)	$ (8,535)
Adjustments to reconcile net loss to net used in operating activities:
Depreciation and amortization	199	191
Discount amortization on convertible note	633	146
Stock-based compensation expense	606	1,226
Bad debt expense	833	280
Accrued interest on convertible notes	(13)	27
Amortization of operating lease right of use assets	393	0
Change in fair value of warrants	(258)	(3,691)
Changes in operating assets and liabilities:
Accounts receivable	(1,815)	(1,990)
Prepaid expenses and other current assets	292	(1,499)
Contract assets	44	16
Accounts payable and other liabilities	1,558	1,630
Operating lease liabilities	(403)	0
Deferred payroll tax credits	1,751	0
Deferred revenue	(256)	(120)
Net cash provided by (used in) operating activities	(3,468)	(12,318)
Cash flows from investing activities:
Purchase of convertible note	(10)	(256)
Purchases of property and equipment	(249)	(143)
Net cash used in investing activities	(259)	(399)
Cash flows from financing activities:
Business combination, net of cash acquired	0	10,185
Proceeds from short-term cash advance	1,000	0
Repayment of short-term cash advance	(220)	0
Proceeds from convertible notes	0	7,000
Proceeds from related party payable	125	0
Repayment of convertible notes	(3,088)	0
Proceeds from issuance of common stock	2,661	0
Cost of equity issuance	(278)	0
Proceeds from exercise of stock options	274	112
Net cash (used in) provided by financing activities	474	17,297
Net increase (decrease) in cash and cash equivalents	(3,253)	4,580
Cash and cash equivalents at beginning of period	3,546	2,227
Cash and cash equivalents at end of period	293	6,807
Supplemental cash flows disclosures
Conversion of convertible note and outstanding interest into common stock	1,250	7,305
Warrant assumed in business combination at estimated fair value	0	4,496
Right-of-use assets in exchange for new operating lease liabilities	165	0
Legal settlements satisfied through issuance of common stock	263	0
Satisfaction of professional fees through issuance of commons stock	18	0
Cost of equity issuance deducted from proceeds	342	0
Interest paid	$ 467	$ 0